Viewing Study NCT05720533


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2026-01-26 @ 11:27 PM
Study NCT ID: NCT05720533
Status: UNKNOWN
Last Update Posted: 2023-02-09
First Post: 2023-01-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer
Sponsor:
Organization: